The WORLD ANTI-DOPING AGENCY (WADA) will be asked by the INTERNATIONAL OLYMPIC COMMITTEE (IOC) whether they will investigate all athletes associated with the Nike Oregon Project (NOP), following the banning of COACH ALBERTO SALAZAR.
IOC President THOMAS BACH described the case involving Salazar, banned for four years earlier this week, as “very concerning”.
The UNITED STATES ANTI-DOPING AGENCY (USADA) revealed SALAZAR’S punishment was for “orchestrating and facilitating prohibited doping conduct” as head coach of the NOP, a camp designed primarily to develop US endurance athletes.
It was attended for some years by BRITAIN’S multiple Olympic and world champion SIR MO FARAH until he severed his contract and switched coaches.
USADA alleged SALAZAR trafficked banned performance-enhancing substance testosterone to multiple athletes.
SALAZAR was also said to have tampered, or attempted to tamper, with NOP athletes’ doping control process, the Agency concluded after concluding its four-year investigation.
JEFFREY BROWN, a paid consultant endocrinologist for NOP on performance enhancement and who served as a physician for numerous athletes in the training programme, also received a four-year ban.
So far, no athletes have been charged with any offences.
BACH promised he would write a letter to WADA to find out further details around the case.
This includes whether results at the Olympic Games may have been impacted by possible doping offences.
“First of all, we want to find out how many athletes have been investigated,” Bach said, following the IOC Executive Board meeting .
Athletes coached by SALAZAR have received notice from the Athletics Integrity Unit (AIU) prohibiting them from future association.
They include Sifan Hassan, the Ethiopian-born athlete now representing The NETHERLANDS who won the women’s 10,000 metres title at the IAAF World Championships in DOHA.
DAVID HOWMAN, chairman of the AIU, told insidethegames earlier this week there was no direct assumption made about any athlete who may have worked with SALAZAR.